Epidemiological trends among the population with chronic HCV infection in the Netherlands

被引:0
作者
Maan, Raoel [1 ]
Toes-Zoutendijk, Esther [2 ]
Veldt, Bart J. [1 ]
Hansen, Bettina E. [1 ]
van der Meer, Adriaan J. [1 ]
de Knegt, Robert J. [1 ]
机构
[1] Erasmus MC Univ Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands
[2] Erasmus MC Univ Med Ctr Rotterdam, Dept Publ Hlth, Rotterdam, Netherlands
关键词
HEPATITIS-C VIRUS; SUSTAINED VIROLOGICAL RESPONSE; HUMAN-IMMUNODEFICIENCY-VIRUS; SIMPLE NONINVASIVE INDEX; TREATMENT-NAIVE PATIENTS; INTERFERON-ALPHA; 2A; UNITED-STATES; PLUS RIBAVIRIN; LIVER FIBROSIS; HEPATOCELLULAR-CARCINOMA;
D O I
10.3851/IMP2996
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: As the field of antiviral therapy for chronic HCV infection is rapidly evolving, this study aimed to assess the epidemiological changes in patient and disease characteristics among individuals with chronic HCV infection. Methods: This study included all consecutive patients with chronic HCV monoinfection who were referred between 1990 and 2013 to the Erasmus MC University Medical Center Rotterdam, a large tertiary centre in the Netherlands. To identify trends over time, the study population was divided into six equal eras based on date of first visit to the outpatient clinic. Results: A total of 1,779 patients were diagnosed with chronic HCV infection. Mean age increased over time from 43.6 (SD 13.8) years to 51.7 (SD 11.2) years (P<0.001). The number of patients who were referred with cirrhosis increased over time, from 31 (25%) patients in Era 1 to 118 (42%) patients in Era 6 (P<0.001), respectively. More patients were referred with HCV genotype la and 3 in the last era, with 27 (48.2%) and 15 (14.0%) patients in Era 1 and 58 (54.2%) and 60 (21.8%) patients in Era 6 (P<0.001 both), respectively. The vast majority of patients (69.5%) were born between 1950 to 1975, with 62.5% of the patients being born between 1945 and 1965. Conclusions: The HCV-infected population is ageing and is more often referred with severe liver disease. This study stresses the importance of urgently implementing national HCV screening programmes in order to be able to decrease the future burden of chronic HCV infection in the Netherlands.
引用
收藏
页码:207 / 215
页数:9
相关论文
共 56 条
[1]   Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection [J].
Afdhal, Nezam ;
Reddy, K. Rajender ;
Nelson, David R. ;
Lawitz, Eric ;
Gordon, Stuart C. ;
Schiff, Eugene ;
Nahass, Ronald ;
Ghalib, Reem ;
Gitlin, Norman ;
Herring, Robert ;
Lalezari, Jacob ;
Younes, Ziad H. ;
Pockros, Paul J. ;
Di Bisceglie, Adrian M. ;
Arora, Sanjeev ;
Subramanian, G. Mani ;
Zhu, Yanni ;
Dvory-Sobol, Hadas ;
Yang, Jenny C. ;
Pang, Phillip S. ;
Symonds, William T. ;
McHutchison, John G. ;
Muir, Andrew J. ;
Sulkowski, Mark ;
Kwo, Paul .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (16) :1483-1493
[2]   A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C-Associated Liver Cirrhosis [J].
Aleman, Soo ;
Rahbin, Nogol ;
Weiland, Ola ;
Davidsdottir, Loa ;
Hedenstierna, Magnus ;
Rose, Nina ;
Verbaan, Hans ;
Stal, Per ;
Carlsson, Tony ;
Norrgren, Hans ;
Ekbom, Anders ;
Granath, Fredrik ;
Hultcrantz, Rolf .
CLINICAL INFECTIOUS DISEASES, 2013, 57 (02) :230-236
[3]   Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection [J].
Bacon, Bruce R. ;
Gordon, Stuart C. ;
Lawitz, Eric ;
Marcellin, Patrick ;
Vierling, John M. ;
Zeuzem, Stefan ;
Poordad, Fred ;
Goodman, Zachary D. ;
Sings, Heather L. ;
Poordad, Fred ;
Goodman, Zachary D. ;
Sings, Heather L. ;
Boparai, Navdeep ;
Burroughs, Margaret ;
Brass, Clifford A. ;
Albrecht, Janice K. ;
Esteban, Rafael .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (13) :1207-1217
[4]   An algorithm for the grading of activity in chronic hepatitis C [J].
Bedossa, P ;
Poynard, T .
HEPATOLOGY, 1996, 24 (02) :289-293
[5]   Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients [J].
Benhamou, Y ;
Bochet, M ;
Di Martino, V ;
Charlotte, F ;
Azria, F ;
Coutellier, A ;
Vidaud, M ;
Bricaire, F ;
Opolon, P ;
Katlama, C ;
Poynard, T .
HEPATOLOGY, 1999, 30 (04) :1054-1058
[6]   ISOLATION OF A CDNA CLONE DERIVED FROM A BLOOD-BORNE NON-A, NON-B VIRAL-HEPATITIS GENOME [J].
CHOO, QL ;
KUO, G ;
WEINER, AJ ;
OVERBY, LR ;
BRADLEY, DW ;
HOUGHTON, M .
SCIENCE, 1989, 244 (4902) :359-362
[7]   Aging of Hepatitis C Virus (HCV)-Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression [J].
Davis, Gary L. ;
Alter, Miriam J. ;
El-Serag, Hashem ;
Poynard, Thierry ;
Jennings, Linda W. .
GASTROENTEROLOGY, 2010, 138 (02) :513-U141
[8]   The changing epidemiology of hepatitis C virus infection in the United States: National health and nutrition examination survey 2001 through 2010 [J].
Ditah, Ivo ;
Ditah, Fausta ;
Devaki, Pardha ;
Ewelukwa, Oforbuike ;
Ditah, Chobufo ;
Njei, Basile ;
Luma, Henry N. ;
Charlton, Michael .
JOURNAL OF HEPATOLOGY, 2014, 60 (04) :691-698
[9]   THE DECLINING RISK OF POSTTRANSFUSION HEPATITIS-C VIRUS-INFECTION [J].
DONAHUE, JG ;
MUNOZ, A ;
NESS, PM ;
BROWN, DE ;
YAWN, DH ;
MCALLISTER, HA ;
REITZ, BA ;
NELSON, KE .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (06) :369-373
[10]   Cost-effectiveness of Screening for Chronic Hepatitis C Infection in the United States [J].
Eckman, Mark H. ;
Talal, Andrew H. ;
Gordon, Stuart C. ;
Schiff, Eugene ;
Sherman, Kenneth E. .
CLINICAL INFECTIOUS DISEASES, 2013, 56 (10) :1382-1393